Intangible Assets (Tables)

9 Months Ended

Jun. 30, 2013

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Finite-Lived Intangible Assets [Table Text Block]

Intangible assets at June 30, 2013 and September 30, 2012 consist of the following:

	Useful	Gross		Accumulated
June 30, 2013	Life (years)	Amount		Amortization		Net
Acquired Customer Base	5-15	$	5,275,668	$	2,658,925	$	2,616,743
Know How	15		512,000		170,749		341,251
Trade Names	15 - Indefinite		527,389		74,203		453,186
Biomedical Technologies	5		300,000		105,003		194,997
		$	6,615,057	$	3,008,880	$	3,606,177

	Useful	Gross		Accumulated
September 30, 2012	Life (years)	Amount		Amortization		Net
Acquired Customer Base	5-15	$	7,858,775	$	2,257,533	$	5,601,242
Know How	15		512,000		145,147		366,853
Trade Names	15 - Indefinite		558,435		63,222		495,213
Biomedical Technologies	5		300,000		60,003		239,997
		$	9,229,210	$	2,525,905	$	6,703,305

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]

Amortization expense for the three months ended June 30, 2013 and 2012 was $170,304 and $162,802 respectively. Amortization expense for the nine months ended June 30, 2013 and 2012 was $495,079 and $488,407, respectively. Estimated amortization expense for each of the next five fiscal years is as follows: 

	2013 (3 Months)		2014		2015		2016		2017		Thereafter		Total
Acquired Customer Base	$	128,867	$	543,085	$	543,085	$	543,085	$	543,085	$	315,504	$	2,616,711
Know How		8,533		34,133		34,133		34,133		34,133		196,187		341,252
Trade Names		3,650		14,600		14,600		14,600		14,600		72,995		135,045
Biomedical Technologies		15,000		60,000		60,000		59,997		0		0		194,997
	$	156,050	$	651,818	$	651,818	$	651,815	$	591,818	$	584,686	$	3,288,005